Deutsche Bank Ag\ Alkermes Plc. Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Alkermes Plc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 224,670 shares of ALKS stock, worth $7.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224,670
Previous 226,158
0.66%
Holding current value
$7.78 Million
Previous $6.33 Million
2.07%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$641 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$425 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$305 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$262 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.69B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...